Error loading player: No playable sources found
Critical Attributes Analysis and Method Lifecycle Management for Biologics and ATMPs – Selection of Assay Platforms and Data Processing Methods for Potency Assurance | Presented by BioAgilytix Labs
Date
January 28, 2025
This product is not available for individual purchase, but it is available as part of the following products:
Session Speakers:
Jeff Patrick, BioAgilytix Labs
Shiqian Zhu, BioAgilytix Labs
Speakers
General
Related Products
Parallel Session 2B- LER 2025: Strategies Today for Overcoming Low Endotoxin Recovery
Monitoring and control of endotoxin are critical aspects of an overall microbial control strategy necessary to ensure drug product quality and patient safety…
Parallel Session 2A - Science vs the Fear Factor: Alternative Potency Assays for Recombinant Biologics and Vaccines
Potency analytical control strategies are critical to support biopharmaceutical drug and vaccine development throughout the product lifecycle…
Parallel Session 5B - Immunogenicity Risk and Control
Peptides, proteins and oligonucleotide are becoming essential medical treatments for many progressive, debilitating, or life-threatening diseases. However, the development of these potential therapies can be derailed by product immunogenicity as it can impact on safety and efficacy…
Parallel Session 5A - Integrated Control Strategy for Combination Products
Drug-device combination products such as prefilled syringes, autoinjectors, etc. can play an important role to ensure patient convenience, compliance, and enhance therapeutic impact of the drug…
